Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept for Polypoidal Choroidal Vasculopathy Long-term Study
CTR20161025Phase 4Completed
- Sponsor
- Chengdu Kanghong Biotechnology Co., Ltd.
- Start
- Apr 2017
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of conbercept in polypoidal choroidal vasculopathy (PCV), sponsored by Chengdu Kanghong Biotechnology Co., Ltd.. Started Apr 2017; status: completed.
02
Drugs
conbercept
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on CTR20161025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20161025.